Clinical trial naming conventions
Background
Acronyms were first used to identify clinical trials in the 1970s.
The term "acronymophilia" was coined in 1994 to refer to the overuse of acronyms in medicine.[6]
An article in the
Examples
A scientific study ranking acronyms was published in the
In a letter to the International Journal of Cardiology, Tsung O. Cheng called out his own field as prone to overuse of contrived acronyms, calling it a "persistent problem". He was spurred to write the letter after he reviewed nine articles about a study named "ZAHARA" without finding any explanation of what the acronym meant.[3][7][8]
Other clinical trials that have been noted in publications for their acronyms include: TORPEDO (Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention (PEVI) in Deep Venous Occlusion)[9] and BATMAN (Bisphosphonate and Anastrozole Trial – Bone Maintenance Algorithm Assessment).[9]
See also
- CALERIE
- ALMANAC
- PARAMOUNT trial
- JUPITER trial
- PROVE-IT TIMI 22
- RECOVERY trial
References
- ^ Lowe, Derek (18 July 2019). "Acronym Fever. We Need an Acronym For That". In the Pipeline. Retrieved 1 May 2020.
- PMID 16823008.
- ^ PMID 14677733.
- ^ PMID 25516539.
- ^ S2CID 31188922.
- PMID 11087292.
- PMID 18692260. Retrieved 1 May 2020.
- PMID 10751783.
- ^ a b "Clinical trial names can be quite AMUSING, but they don't include unicorns : Spoonful of Medicine". blogs.nature.com. Retrieved 1 May 2020.